Windtree Therapeutics, Inc.
WINT
$1.20
-$0.105-8.08%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.92M | 7.73M | 8.56M | 8.70M | 9.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.86M | 24.81M | 17.54M | 16.84M | 15.64M |
| Operating Income | -24.86M | -24.81M | -17.54M | -16.84M | -15.64M |
| Income Before Tax | -9.64M | -11.07M | -5.85M | -20.29M | -26.20M |
| Income Tax Expenses | 71.00K | 311.00K | 114.00K | -- | -1.37M |
| Earnings from Continuing Operations | -9.71 | -11.38 | -5.96 | -20.29 | -24.83 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.71M | -11.38M | -5.96M | -20.29M | -24.83M |
| EBIT | -24.86M | -24.81M | -17.54M | -16.84M | -15.64M |
| EBITDA | -24.68M | -24.67M | -17.46M | -16.76M | -15.55M |
| EPS Basic | -1.26K | -1.05K | -- | -- | -- |
| Normalized Basic EPS | -750.58 | -642.77 | -- | -- | -- |
| EPS Diluted | -1.26K | -1.05K | -- | -- | -- |
| Normalized Diluted EPS | -750.58 | -642.77 | -- | -- | -- |
| Average Basic Shares Outstanding | 29.20K | 11.50K | -- | -- | -- |
| Average Diluted Shares Outstanding | 29.20K | 11.50K | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -3.57% | -- | -- | -- | -- |
